CORC

在结果中检索

CORC

浏览/检索结果: 共24条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Pyrotinib as neoadjuvant therapy for HER2+breast cancer: A multicenter, randomized, controlled, phase II trial. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Ding, Xiaowen;  Mo, Wenju;  Xie, Xiaohong;  Wang, Ouchen;  Ding, Yuqin
收藏  |  浏览/下载：14/0  |  提交时间：2022/01/10
Pyrotinib plus capecitabine for HER2-positive metastatic breast cancer patients with brain metastases (PERMEATE): A multicenter, single-arm phase II study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Yan, Min;  Ouyang, Quchang;  Sun, Tao;  Niu, Limin;  Yang, Jin
收藏  |  浏览/下载：12/0  |  提交时间：2022/01/10
Dual-targeted therapy with pyrotinib and trastuzumab for HER2-positive advanced colorectal cancer: Preliminary results from a multicenter phase 2 trial. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Yuan, Ying;  Fu, Xianhua;  Ying, Jieer;  Yang, Liu;  Fang, Weijia
收藏  |  浏览/下载：7/0  |  提交时间：2022/01/10
Efficacy of Pyrotinib in HER2-Overexpressing Salivary Duct Carcinoma With Lung Metastasis: A Case Report 期刊论文
FRONTIERS IN ONCOLOGY, 2020, 卷号: 10
作者:  Yang, Zi-yan;  Huang, Jia-huan;  Chen, Bo;  Xu, Chun-wei;  Lei, Lei
收藏  |  浏览/下载：26/0  |  提交时间：2020/11/30
Characterization of covalent binding of tyrosine kinase inhibitors to plasma proteins 期刊论文
DRUG METABOLISM AND PHARMACOKINETICS, 2020, 卷号: 35, 期号: 5, 页码: 456-465
作者:  Liu, Xiaoyun;  Feng, Dan;  Zheng, Mingyue;  Cui, Yongmei;  Zhong, Dafang
收藏  |  浏览/下载：13/0  |  提交时间：2020/12/21
Safety, Efficacy, and Biomarker Analysis of Pyrotinib in Combination with Capecitabine in HER2-Positive Metastatic Breast Cancer Patients: A Phase I Clinical Trial 期刊论文
CLINICAL CANCER RESEARCH, 2019, 卷号: 25, 期号: 17, 页码: 5212-5220
作者:  Li, Qiao;  Guan, Xiuwen;  Chen, Shanshan;  Yi, Zongbi;  Lan, Bo
收藏  |  浏览/下载：15/0  |  提交时间：2020/07/01
Pyrotinib or Lapatinib Combined With Capecitabine in HER2-Positive Metastatic Breast Cancer With Prior Taxanes, Anthracyclines, and/or Trastuzumab: A Randomized, Phase II Study 期刊论文
2019, 卷号: 37, 期号: 29, 页码: 2610-2619
作者:  Ma Fei;  Ouyang Quchang;  Li Wei;  Jiang Zefei;  Tong Zhongsheng
收藏  |  浏览/下载：32/0  |  提交时间：2020/01/03
Safety, Efficacy, and Biomarker Analysis of Pyrotinib in Combination with Capecitabine in HER2-Positive Metastatic Breast Cancer Patients: A Phase I Clinical Trial 期刊论文
2019, 卷号: 25, 期号: 17, 页码: 5212-5220
作者:  Li Qiao;  Guan Xiuwen;  Chen Shanshan;  Yi Zongbi;  Lan Bo
收藏  |  浏览/下载：6/0  |  提交时间：2020/01/03
metabolismanddispositionofpyrotinibinhealthymalevolunteerscovalentbindingwithhumanplasmaprotein 期刊论文
actapharmacologicasinica, 2019, 卷号: 40, 期号: 7, 页码: 980
作者:  Meng Jian;  Liu Xiaoyun;  Ma Sheng;  Zhang Hua;  Yu Songda
收藏  |  浏览/下载：1/0  |  提交时间：2020/07/01
Metabolism and disposition of pyrotinib in healthy male volunteers: covalent binding with human plasma protein 期刊论文
Acta pharmacologica Sinica, 2018
作者:  Meng, Jian;  Liu, Xiao-Yun;  Ma, Sheng;  Zhang, Hua;  Yu, Song-da
收藏  |  浏览/下载：98/0  |  提交时间：2019/01/08

©版权所有 ©2017 CSpace - Powered by CSpace